Wealthspire Advisors (Maryland)’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21	Closed	-$3K	–	2196
2019 Q1	$3K	Buy	21 +4	+24%	+$773	﹤0.01%	2078
2018 Q4	$3K	Hold	17	–	–	﹤0.01%	2012
2018 Q3	$4K	Hold	17	–	–	﹤0.01%	1953
2018 Q2	$4K	Hold	17	–	–	﹤0.01%	1930
2018 Q1	$4K	Buy	+17	New	+$4.46K	﹤0.01%	1952

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s DMK Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2019, closing a stake of 21 shares — an estimated $3K sold.

Wealthspire Advisors (Maryland) first reported a position in DMK in Q1 2018 and held it in 5 quarters. The position peaked at $4K in Q3 2018. 51 funds tracked by Wall St. Rank hold DMK as of Q2 2019.

Wealthspire Advisors (Maryland) reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2019 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 21 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2019, an estimated $3K.
Wealthspire Advisors (Maryland) first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2018 and held it in 5 quarters.
Wealthspire Advisors (Maryland)'s DMK Pharmaceuticals Corporation Common Stock position peaked at $4K in Q3 2018.
51 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.